All news

Genzyme targets BBB

Genzyme targets BBB

By Nick Taylor

Genzyme is evaluating to-BBB’s G-Technology as part of a research collaboration aimed at developing treatments capable of crossing the blood-brain barrier (BBB).

West laying off 100 staff

West laying off 100 staff

By Nick Taylor

West Pharmaceutical Services is laying off 100 staff as part of restructuring efforts after its third quarter results fell short of expectations, despite operating profit increasing by 45 per cent.

Novartis invests in China

Novartis invests in China

By Nick Taylor

Novartis is investing $250m (€170m) to construct a facility in China focused on research, development and manufacture of APIs and has earmarked a further $1bn to expand its R&D activities in the country.

Follow us

Products

View more

Webinars